The FDA analysts also raised concerns about whether women with medical conditions that should preclude them from taking the pill, primarily breast cancer and undiagnosed vaginal bleeding, would avoid the product.
"By tracking every financial transaction, they will have access to every detail of our spending, the recipient of our money, and how we allocate our resources," says Kiyosaki.
